Skip to main content
Figure 4 | Annals of General Psychiatry

Figure 4

From: Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Figure 4

Factors that may reduce relapse rates. Individual citations of each factor: a single reference may include citations of more than one factor. The antipsychotic medication category does not include the other pharmacological therapy factors. Non-pharmacological therapies [46, 11, 1416, 27, 32, 41, 42, 64],[82, 84, 92, 118121]; antipsychotic medication [4, 6, 23, 54, 81, 122127]; risperidone/risperidone long-acting injectable (RLAI) specifically [2224, 35, 65, 74, 128131]; medication compliance [25, 33, 132, 133]; Information Technology Aided Relapse Prevention in Schizophrenia (ITAREPS) [52]; good patient insight [134]; early detection [135]; greater frequency of electroconvulsive therapy (ECT) [90]; olanzapine specifically [21].

Back to article page